Which hedge funds own CRL? CHARLES RIV LABS INTL INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
12 of the hedge funds tracked by WhaleCreep disclosed a position in CRL (CHARLES RIV LABS INTL INC) in their Q2 2026 13F filings, worth $516.1m in total. The largest holder by portfolio weight is SRS Investment Management at 0.4% of its book. 3 managers opened a new position this quarter: SRS Investment Management, Avidity Partners, Suvretta Capital Management. 2 exited: Bridgewater Associates, Maverick Capital.
12tracked managers holding
3opened this quarter
2exited this quarter
Which hedge funds hold CRL? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| SRS Investment Management | Q2 2026 | 0.4% | $42.5m | 187,384 | – | new |
| Avidity Partners | Q2 2026 | 0.4% | $2.3m | 10,000 | – | new |
| Citadel Advisors | Q2 2026 | 0.2% | $270.7m | 1,193,601 | -2% | reduced |
| Millennium Management | Q2 2026 | 0.1% | $110.3m | 486,462 | -48% | reduced |
| Marshall Wace | Q2 2026 | 0.1% | $77.8m | 342,995 | 129% | added |
| Moore Capital Management | Q2 2026 | 0.0% | $882.7k | 3,892 | -91% | reduced |
| Horizon Kinetics | Q2 2026 | 0.0% | $1.6m | 7,103 | -42% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $863.6k | 3,808 | -33% | reduced |
| Woodline Partners | Q2 2026 | 0.0% | $1.8m | 7,764 | 1% | added |
| Suvretta Capital Management | Q2 2026 | 0.0% | $229.1k | 1,010 | – | new |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $7.2m | 31,587 | -84% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $12.7k | 56 | -66% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Bridgewater Associates | 0.2% | $1.2m |
| Maverick Capital | 0.1% | $1.4m |
How has hedge fund ownership of CRL changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 12 | $516.1m |
| Q1 2026 | 11 | $443.9m |
| Q4 2025 | 12 | $150.6m |
| Q3 2025 | 6 | $38.6m |
| Q2 2025 | 7 | $115.9m |
| Q1 2025 | 9 | $390.8m |
| Q4 2024 | 9 | $548.0m |
| Q3 2024 | 7 | $311.4m |
| Q2 2024 | 7 | $53.6m |
| Q1 2024 | 10 | $111.7m |
| Q4 2023 | 10 | $169.7m |
| Q3 2023 | 8 | $126.5m |
| Q2 2023 | 7 | $114.8m |
| Q1 2023 | 9 | $137.4m |
| Q4 2022 | 9 | $178.2m |
| Q3 2022 | 8 | $293.2m |
Counts every tracked manager that disclosed CRL in that quarter's filing, including managers that have since stopped filing.